Brief: Kamada Submits Application To The U.S. FDA To Manufacture Cytogam

Kamada

04/01/2023 12:44

Jan 4 (Reuters) - Kamada Ltd  KMDA.TA :
    * KAMADA ANNOUNCES SUBMISSION OF APPLICATION TO THE U.S. FDA
TO
MANUFACTURE CYTOGAM® AT THE COMPANY’S FACILITY IN ISRAEL
    * KAMADA ANNOUNCES SUBMISSION OF APPLICATION TO THE U.S. FDA
TO
MANUFACTURE CYTOGAM® AT THE COMPANY’S FACILITY IN ISRAEL
    * KAMADA LTD - FDA APPROVAL CURRENTLY EXPECTED BY MID-2023

Source text for Eikon:  ID:nGNX6strNj 
Further company coverage:  KMDA.TA 
 ((Reuters.Briefs@thomsonreuters.com;))